Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
Construct financial models with decades of earnings statistics, ratios and valuation data - all exportable - to drive your trade ideas.
Future Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the impressive growth trajectory of the global advanced ...
The summative assessment consisting of statistical analyses and theory questions this will require students to demonstrate their knowledge and understanding of advanced statistics by carrying out ...
Leap Therapeutics stock plummets as it will discontinue DisTinGuish study in advanced gastric cancer
endpoints for patients with advanced gastric cancer. The disappointing outcome has led the company to halt plans for Phase 3 studies in this indication. Leap Therapeutics reported that while the ...
VISTA is currently enrolling. NCT04850118. Beacon Therapeutics is an ophthalmic gene therapy company founded to save and restore the vision of patients with a range of prevalent and rare retinal ...
VISTA is currently enrolling. NCT04850118. Beacon Therapeutics is an ophthalmic gene therapy company founded to save and restore the vision of patients with a range of prevalent and rare retinal ...
If you’re having trouble seeing the stats on your mobile device, click here. Sign up for more Orange basketball analysis from Donna Ditota in our ‘Posting Up’ newsletter. Try the newsletter ...
LEXINGTON, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and ...
The upstart, clinical stage biotech company Viking Therapeutics, Inc. (NASDAQ:VKTX), which is attempting to disrupt their market leadership has also suffered from a protracted hangover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback